Clinical Trial: Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse
Study Status: Completed
Recruit Status: Completed
Condition:
Inflammatory Bowel Diseases
Rheumatic Disorder
Study Type: Observational
Official Title: Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse
Brief Summary:
This study is a retrospective pharmacological study, of a historical cohort. Collection of Retrospective data from February 2020 to 30 September 2021 The index date is the date of COVID-19 positive PCR test. The data will be collected until last news (last clinical visit or death).There are no defined study visits. In the course of the study, the clinical data recorded are those corresponding to the standard medical procedure.The goal of this study is to assess the impact on continuing or stopping adalimumab…
Read more